Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
The NMDA receptor is a critical component of synaptic plasticity and neurotransmission in the brain. Understanding its intricate functions is paramount for advancements in neuroscience and the development of novel therapeutic agents. NINGBO INNO PHARMCHEM CO.,LTD. contributes to this field by providing GLYX-13, a specialized peptide that offers unique insights into NMDA receptor modulation.
GLYX-13, also known as Rapastinel, is a synthetic peptide that acts as a partial agonist at the glycine site of the NMDA receptor. This site is crucial for the receptor's activation and function. By binding to this allosteric site, GLYX-13 modulates the receptor's response, exhibiting a balanced effect that promotes long-term potentiation (LTP) – a cellular mechanism underlying learning and memory – while also reducing long-term depression (LTD). This dual action is what makes GLYX-13 such an interesting research chemical.
The significance of NMDA receptor modulation extends to cognitive function and mood regulation. GLYX-13's ability to fine-tune these processes has led to its investigation as a potent nootropic. Researchers are keen to buy GLYX-13 to study its effects on memory, learning, and overall cognitive performance. NINGBO INNO PHARMCHEM CO.,LTD. ensures the availability of high-purity GLYX-13 to support these critical scientific endeavors.
Furthermore, the antidepressant properties of GLYX-13 are closely linked to its NMDA receptor activity. By enhancing certain downstream signaling pathways, GLYX-13 can contribute to mood improvement and has shown promise in treating treatment-resistant depression. This highlights the therapeutic potential of targeted NMDA receptor modulation, a concept that NINGBO INNO PHARMCHEM CO.,LTD. actively supports through its product offerings.
The peptide synthesis for nootropics and other neuroactive compounds is a core expertise of NINGBO INNO PHARMCHEM CO.,LTD. We are committed to providing the scientific community with access to cutting-edge compounds like GLYX-13. Our role in supplying this peptide enables researchers to explore the complex mechanisms of the NMDA receptor and its implications for neurological health and disease.
In essence, GLYX-13 serves as a valuable tool for understanding NMDA receptor function. Its unique partial agonism at the glycine site offers a nuanced approach to modulating brain activity, with implications for cognitive enhancement and psychiatric treatment. NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to supporting this vital research by ensuring a consistent supply of high-quality GLYX-13.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
